Christopher R. Loose, Chief Scientific Officer at Frequency Therapeutics, Inc. (FREQ), sold 2,771 shares at $0.61 ($2K) on 2023-07-21, disclosed to the SEC on 2023-07-25.
Scheduled sale ($2k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.61 | 1,333 | $813 | 51.2% |
| 2 | $0.54 | 1,438 | $777 | 48.8% |
| Total | $0.57 avg | 2,771 | $2K | 100% |
| Filing → |
| FREQ | SELL | 2023-07-21 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-19 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-17 | $1K | — | Filing → |